Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$35,200.00
Jan 3, 2022
For-profit organization
Development and validation of T Cell Immunoassay for immuno-oncology
983842
This project will involve the development and validation of an assay to detect tumor associated antigen (TAA) and tumor neoantigen (TN)-specific cancer fighting T cells in a small sample of peripheral blood to as a diagnostic assay to 1) identify candidates for immune checkpoint inhibitor (ICI) treatment and 2) assess the ability to mount an anti-tumor immune response after immunotherapy or chemotherapy.
$36,000.00
May 3, 2021
For-profit organization
Youth Technician
971569
The candidate will be involved in preparation and quantitation of the frequency of anti-SARS-CoV-2 T cells using the enzyme-linked immune absorbent spot (ELISpot) assay.
$50,000.00
Feb 1, 2021
For-profit organization
Development of T Cell Immunoassay for COVID-19 and other diseases
964595
The project will involve the development of a diagnostic test to detect anti-SARS-CoV-2-specific T cells in a small sample of peripheral blood with initial aim to test vaccine effectiveness in terms of cell mediated immunity and understand which vaccine recipients are potentially immune to COVID-19 to triage vaccine prioritization in Canada.